Phenominer Database Results (46 results)

 
 
How to display a graph
Strain Phenotype Conditions Study Experiment Name Sex Age # of Animals Value Units SEM SD Method Method Duration Post Insult Time Value Method Notes Clinical Measurement Notes Record ID Study ID
ISIAH thymus weight to body weight ratio control condition Shurligina AV, et al., Bull Exp Biol Med. 2013 Aug;155(4):421-4. doi: 10.1007/s10517-013-2167-4. thymus mass male 150 days-180 days 10 1.89 mg/g 0.21 0.66 post excision weight measurement 0.0 0 107687 3096
ISIAH CD4+CD8+ thymocyte count control condition Shurligina AV, et al., Bull Exp Biol Med. 2013 Aug;155(4):421-4. doi: 10.1007/s10517-013-2167-4. thymocyte quantity male 150 days-180 days 10 363.84 x10E6/organ 38.81 122.73 flow cytometry method 0.0 0 cd4+cd8+ t-cell 107765 3096
ISIAH CD4+CD25+ thymocyte count control condition Shurligina AV, et al., Bull Exp Biol Med. 2013 Aug;155(4):421-4. doi: 10.1007/s10517-013-2167-4. thymocyte quantity male 150 days-180 days 10 23.15 x10E6/organ 6.34 20.05 flow cytometry method 0.0 0 cd4+cd25+ t-cell 107771 3096
ISIAH diastolic blood pressure control condition Shurligina AV, et al., Bull Exp Biol Med. 2013 Aug;155(4):421-4. doi: 10.1007/s10517-013-2167-4. arterial blood pressure trait male 150 days-180 days 10 111.0 mmHg 9.7 30.67 unspecified method 0.0 0 107673 3096
ISIAH amount of time spent making head dipping movements in an experimental apparatus control condition Ragaeva DS, et al., Physiol Behav. 2017 Jun 1;175:22-30. doi: 10.1016/j.physbeh.2017.03.026. Epub 2017 Mar 21. head movement trait male 84 days-98 days 13 22.45 s 2.78 10.02 elevated plus maze apparatus method 300.0 0 within elevated plus maze head dips duration 110715 3182
ISIAH time to first head dip within an experimental apparatus control condition Ragaeva DS, et al., Physiol Behav. 2017 Jun 1;175:22-30. doi: 10.1016/j.physbeh.2017.03.026. Epub 2017 Mar 21. head movement trait male 84 days-98 days 13 20.08 s 5.94 21.42 elevated plus maze apparatus method 300.0 0 within elevated plus maze head dips latency 110717 3182
ISIAH amount of time spent exploring a novel object in an experimental apparatus control condition Ragaeva DS, et al., Physiol Behav. 2017 Jun 1;175:22-30. doi: 10.1016/j.physbeh.2017.03.026. Epub 2017 Mar 21. exploratory behavior trait male 84 days-98 days 13 52.39 s 4.57 16.48 open field apparatus method 300.0 0 NOR test; possibly three-chamber assay (MMO:0000604) novel object exploration duration 110725 3182
ISIAH amount of time spent exploring a familiar object in an experimental apparatus control condition Ragaeva DS, et al., Physiol Behav. 2017 Jun 1;175:22-30. doi: 10.1016/j.physbeh.2017.03.026. Epub 2017 Mar 21. exploratory behavior trait male 84 days-98 days 13 15.56 s 3.69 13.3 open field apparatus method 300.0 0 NOR test; possibly three-chamber assay (MMO:0000604) familiar object exploration duration 110727 3182
ISIAH body weight control condition Ragaeva DS, et al., Physiol Behav. 2017 Jun 1;175:22-30. doi: 10.1016/j.physbeh.2017.03.026. Epub 2017 Mar 21. body mass male 25 days 13 51.1 g 11.3 40.74 body weighing method 0.0 0 110675 3182
ISIAH heart wet weight control condition Redina OE, et al., Clin Exp Pharmacol Physiol. 2006 May-Jun;33(5-6):456-64. heart mass not specified 180 days 11 1.1 g 0.02 0.07 post excision weight measurement 0.0 0 68053 835
ISIAH blood non-specified leukocyte count control condition Shurligina AV, et al., Bull Exp Biol Med. 2013 Aug;155(4):421-4. doi: 10.1007/s10517-013-2167-4. leukocyte quantity male 150 days-180 days 10 4.33 10E3/ul 1.64 5.19 white blood cell counting method 0.0 0 107695 3096
ISIAH CD4+CD25+ splenocyte count to total splenocyte count ratio control condition Shurligina AV, et al., Bull Exp Biol Med. 2013 Aug;155(4):421-4. doi: 10.1007/s10517-013-2167-4. splenocyte morphology trait male 150 days-180 days 10 2.02 % 0.1 0.32 flow cytometry method 0.0 0 cd4+cd25+ spleen 107741 3096
ISIAH CD11b/c+ splenocyte count to total splenocyte count ratio control condition Shurligina AV, et al., Bull Exp Biol Med. 2013 Aug;155(4):421-4. doi: 10.1007/s10517-013-2167-4. splenocyte morphology trait male 150 days-180 days 10 9.4 % 1.61 5.09 flow cytometry method 0.0 0 cd11b/c+ spleen 107747 3096
ISIAH CD4+CD25+ splenocyte count control condition Shurligina AV, et al., Bull Exp Biol Med. 2013 Aug;155(4):421-4. doi: 10.1007/s10517-013-2167-4. splenocyte morphology trait male 150 days-180 days 10 13.99 x10E6/organ 2.0 6.32 flow cytometry method 0.0 0 cd4+cd25+ spleen 107750 3096
ISIAH gestation period length control condition Ragaeva DS, et al., Physiol Behav. 2017 Jun 1;175:22-30. doi: 10.1016/j.physbeh.2017.03.026. Epub 2017 Mar 21. gestation period duration female 98 days-112 days 5 22.0 d 0.0 0.0 unspecified method 0.0 0 110679 3182
ISIAH systolic blood pressure control condition Ragaeva DS, et al., Physiol Behav. 2017 Jun 1;175:22-30. doi: 10.1016/j.physbeh.2017.03.026. Epub 2017 Mar 21. arterial blood pressure trait male 84 days-98 days 13 180.72 mmHg 5.03 18.14 tail cuff volume pressure recording 0.0 0 110681 3182
ISIAH body weight control condition Ragaeva DS, et al., Physiol Behav. 2017 Jun 1;175:22-30. doi: 10.1016/j.physbeh.2017.03.026. Epub 2017 Mar 21. body mass male 84 days-98 days 13 324.85 g 5.86 21.13 body weighing method 0.0 0 110685 3182
ISIAH both adrenal glands wet weight control condition Redina OE, et al., Clin Exp Pharmacol Physiol. 2006 May-Jun;33(5-6):456-64. adrenal gland mass not specified 180 days 11 52.9 mg 1.5 4.97 post excision weight measurement 0.0 0 68059 835
ISIAH plasma corticosterone level control condition Redina OE, et al., Clin Exp Hypertens. 2010;32(6):364-71. doi: 10.3109/10641961003628502. blood corticosterone amount male 180 days 10 54.0 ng/ml 16.0 50.6 radioimmunoassay 0.0 0 97060 1818
ISIAH both adrenal glands wet weight control condition Redina OE, et al., Clin Exp Hypertens. 2010;32(6):364-71. doi: 10.3109/10641961003628502. adrenal gland mass male 180 days 10 42.1 mg 1.9 6.01 post excision weight measurement 0.0 0 97064 1818
ISIAH systolic blood pressure control condition Redina OE, et al., Clin Exp Pharmacol Physiol. 2006 May-Jun;33(5-6):456-64. arterial blood pressure trait not specified 180 days 11 175.0 mmHg 4.8 15.92 tail cuff plethysmography 0.0 0 68063 835
ISIAH CD45RA+ splenocyte count to total splenocyte count ratio control condition Shurligina AV, et al., Bull Exp Biol Med. 2013 Aug;155(4):421-4. doi: 10.1007/s10517-013-2167-4. splenocyte morphology trait male 150 days-180 days 10 35.23 % 0.8 2.53 flow cytometry method 0.0 0 cd45 RA+ spleen 107744 3096
ISIAH body weight control condition Ragaeva DS, et al., Physiol Behav. 2017 Jun 1;175:22-30. doi: 10.1016/j.physbeh.2017.03.026. Epub 2017 Mar 21. body mass male 7 days 13 11.4 g 1.0 3.61 body weighing method 0.0 0 110671 3182
ISIAH body weight control condition Ragaeva DS, et al., Physiol Behav. 2017 Jun 1;175:22-30. doi: 10.1016/j.physbeh.2017.03.026. Epub 2017 Mar 21. body mass male 14 days 13 21.0 g 1.8 6.49 body weighing method 0.0 0 110673 3182
ISIAH number of stretched-attend posture movements control condition Ragaeva DS, et al., Physiol Behav. 2017 Jun 1;175:22-30. doi: 10.1016/j.physbeh.2017.03.026. Epub 2017 Mar 21. stationary movement trait male 84 days-98 days 13 6.77 null 1.4 5.05 elevated plus maze apparatus method 300.0 0 110719 3182
ISIAH both kidneys wet weight control condition Redina OE, et al., Clin Exp Pharmacol Physiol. 2006 May-Jun;33(5-6):456-64. kidney mass not specified 180 days 11 2.11 g 0.03 0.1 post excision weight measurement 0.0 0 68056 835
ISIAH heart weight to body weight ratio control condition Redina OE, et al., Clin Exp Pharmacol Physiol. 2006 May-Jun;33(5-6):456-64. heart mass not specified 180 days 11 3.63 g/kg 0.07 0.23 post excision weight measurement 0.0 0 68054 835
ISIAH both adrenal glands weight to body weight ratio control condition Redina OE, et al., Clin Exp Pharmacol Physiol. 2006 May-Jun;33(5-6):456-64. adrenal gland mass not specified 180 days 11 17.5 mg/100g 0.5 1.66 post excision weight measurement 0.0 0 68061 835
ISIAH spleen cell count control condition Shurligina AV, et al., Bull Exp Biol Med. 2013 Aug;155(4):421-4. doi: 10.1007/s10517-013-2167-4. spleen morphology trait male 150 days-180 days 10 688.03 x10E6/organ 219.49 694.09 isolated cell counting method 0.0 0 107702 3096
ISIAH CD4-CD8+ thymocyte count control condition Shurligina AV, et al., Bull Exp Biol Med. 2013 Aug;155(4):421-4. doi: 10.1007/s10517-013-2167-4. thymocyte quantity male 150 days-180 days 10 48.72 x10E6/organ 13.72 43.39 flow cytometry method 0.0 0 cd4-cd8+ t-cell 107768 3096
ISIAH systolic blood pressure control condition Shurligina AV, et al., Bull Exp Biol Med. 2013 Aug;155(4):421-4. doi: 10.1007/s10517-013-2167-4. arterial blood pressure trait male 150 days-180 days 10 179.0 mmHg 12.7 40.16 unspecified method 0.0 0 107671 3096
ISIAH litter size control condition Ragaeva DS, et al., Physiol Behav. 2017 Jun 1;175:22-30. doi: 10.1016/j.physbeh.2017.03.026. Epub 2017 Mar 21. single birth offspring quantity female 98 days-112 days 5 8.6 null 2.1 4.7 in vivo visual assessment 0.0 0 110669 3182
ISIAH diastolic blood pressure control condition Ragaeva DS, et al., Physiol Behav. 2017 Jun 1;175:22-30. doi: 10.1016/j.physbeh.2017.03.026. Epub 2017 Mar 21. arterial blood pressure trait male 84 days-98 days 13 141.62 mmHg 7.59 27.37 tail cuff volume pressure recording 0.0 0 110683 3182
ISIAH number of head dipping movements in an experimental apparatus control condition Ragaeva DS, et al., Physiol Behav. 2017 Jun 1;175:22-30. doi: 10.1016/j.physbeh.2017.03.026. Epub 2017 Mar 21. head movement trait male 84 days-98 days 13 12.31 null 1.29 4.65 elevated plus maze apparatus method 300.0 0 within elevated plus maze head dips 110713 3182
ISIAH time to first stretched-attend posture movement within an experimental apparatus control condition Ragaeva DS, et al., Physiol Behav. 2017 Jun 1;175:22-30. doi: 10.1016/j.physbeh.2017.03.026. Epub 2017 Mar 21. stationary movement trait male 84 days-98 days 13 64.78 s 21.32 76.87 elevated plus maze apparatus method 300.0 0 stretch attend posture latency 110723 3182
ISIAH body weight control condition Redina OE, et al., Clin Exp Pharmacol Physiol. 2006 May-Jun;33(5-6):456-64. body mass not specified 180 days 11 302.0 g 4.5 14.92 body weighing method 0.0 0 68062 835
ISIAH both adrenal glands wet weight to body weight ratio control condition Redina OE, et al., Clin Exp Hypertens. 2010;32(6):364-71. doi: 10.3109/10641961003628502. adrenal gland mass male 180 days 10 15.8 mg/100g 0.6 1.9 post excision weight measurement 0.0 0 97066 1818
ISIAH both kidneys wet weight to body weight ratio control condition Redina OE, et al., Clin Exp Pharmacol Physiol. 2006 May-Jun;33(5-6):456-64. kidney mass not specified 180 days 11 7.0 g/kg 0.1 0.33 post excision weight measurement 0.0 0 68058 835
ISIAH CD4-CD25+ splenocyte count control condition Shurligina AV, et al., Bull Exp Biol Med. 2013 Aug;155(4):421-4. doi: 10.1007/s10517-013-2167-4. splenocyte morphology trait male 150 days-180 days 10 4.38 x 10E6/organ 0.82 2.59 flow cytometry method 0.0 0 cd4-cd25+ spleen 107753 3096
ISIAH CD3+ splenocyte count control condition Shurligina AV, et al., Bull Exp Biol Med. 2013 Aug;155(4):421-4. doi: 10.1007/s10517-013-2167-4. splenocyte morphology trait male 150 days-180 days 10 252.6 x10E6/organ 32.4 102.46 flow cytometry method 0.0 0 cd3+ spleen 107756 3096
ISIAH CD11b/c+ splenocyte count control condition Shurligina AV, et al., Bull Exp Biol Med. 2013 Aug;155(4):421-4. doi: 10.1007/s10517-013-2167-4. splenocyte morphology trait male 150 days-180 days 10 66.35 x10E6/organ 17.18 54.33 flow cytometry method 0.0 0 cd11b/c+ spleen 107759 3096
ISIAH CD3+ thymocyte count control condition Shurligina AV, et al., Bull Exp Biol Med. 2013 Aug;155(4):421-4. doi: 10.1007/s10517-013-2167-4. thymocyte quantity male 150 days-180 days 10 611.58 x10E6/organ 83.15 262.94 flow cytometry method 0.0 0 cd3+ thymocyte 107762 3096
ISIAH plasma triglyceride level control condition Shurligina AV, et al., Bull Exp Biol Med. 2013 Aug;155(4):421-4. doi: 10.1007/s10517-013-2167-4. blood triglyceride amount male 150 days-180 days 10 1.39 mmol/l 0.13 0.4 plasma triglyceride analysis 0.0 0 107777 3096
ISIAH plasma total cholesterol level control condition Shurligina AV, et al., Bull Exp Biol Med. 2013 Aug;155(4):421-4. doi: 10.1007/s10517-013-2167-4. blood cholesterol amount male 150 days-180 days 10 62.2 mg/dl 5.4 17.08 plasma total cholesterol measurement test 0.0 0 107783 3096
ISIAH plasma high density lipoprotein phospholipid level control condition Shurligina AV, et al., Bull Exp Biol Med. 2013 Aug;155(4):421-4. doi: 10.1007/s10517-013-2167-4. blood HDL phospholipid amount male 150 days-180 days 10 37.5 mg/dl 2.2 6.96 plasma high-density lipoprotein-cholesterol measurement test 0.0 0 107789 3096
ISIAH amount of time spent making stretched-attend posture movements in an experimental apparatus control condition Ragaeva DS, et al., Physiol Behav. 2017 Jun 1;175:22-30. doi: 10.1016/j.physbeh.2017.03.026. Epub 2017 Mar 21. stationary movement trait male 84 days-98 days 13 13.5 s 3.17 11.43 elevated plus maze apparatus method 300.0 0 stretch attend posture duration 110721 3182